Q3 sales declined due to production issues, but order intake and international expansion remained strong. Spintso divestment boosted results, and Medclair is leveraging climate regulations to drive growth in healthcare and recycling.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.